← Back to search

CELLDEX THERAPEUTICS, INC.

CLDX · NASDAQ

Biological Product (except Diagnostic) Manufacturing

Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly effect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer.